LAKEWOOD-AMEDEX BIOTHERAPEUT
LABT · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.72
- Today’s Low
- $0.66
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.77
- Previous Close
- $0.73
- Volume
- 160.67K
- Market Cap
- $1.73M
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 8031 COOPER CREEK BLVD., UNIVERSITY PARK, FL, UNITED STATES, 34201
- Country
- US
- Listing Date
- 2026-04-23
- Fiscal Year End
- December
- Shares Outstanding
- 1.75M
- CIK
- --
- Website
- lakewoodamedex.com
Labtec Inc. (Ticker: LABT) is a forward-thinking biotechnology company dedicated to revolutionizing drug delivery systems and diagnostic solutions. By leveraging cutting-edge technologies and fostering strategic partnerships, Labtec aims to address critical healthcare challenges and improve patient outcomes. With a comprehensive product portfolio and a strong commitment to meeting unmet medical needs, Labtec is well-positioned for substantial growth in the rapidly evolving biotech sector, representing a compelling investment opportunity for institutional investors.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.78M
2026-03-31
$886.75K
2025-12-31
$712.06K
2025-09-30
$1.88M
Net Income
2026-06-30
-$3.77M
2026-03-31
-$923.29K
2025-12-31
-$744.91K
2025-09-30
-$1.9M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-2.75
2026-03-31
$-1.31
2025-12-31
--
2025-09-30
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.73M
2026-03-31
-$856.85K
2025-12-31
-$681.77K
2025-09-30
-$1.83M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $3.78M | $886.75K | $712.06K | $1.88M |
| Net Income | -$3.77M | -$923.29K | -$744.91K | -$1.9M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-2.75 | $-1.31 | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.73M | -$856.85K | -$681.77K | -$1.83M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.